Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2518495 | 0.82 | LMNA (0.46) | CYP2C9CYP2C19CA12CA1CA2 | |
| SCHEMBL31094801 | 0.81 | PTGS2 (0.43) | CYP2C9CYP2C19CA12CA1CA2 | |
| SCHEMBL9920418 | 0.81 | CYP2C9 (0.42) | CYP2C9CYP2C19CA12CA1CA2 | |
| SCHEMBL1430801 | 0.78 | CYP1A2 (0.44) | CYP2C9CYP2C19CA12CA1CA2 | |
| SCHEMBL29224177 | 0.74 | PTGS2 (0.39) | CYP2C9CYP2C19CA12CA1CA2 | |
| SCHEMBL16815462 | 0.74 | GAA (0.41) | CYP2C9CYP2C19CYP3A4LMNATSHR | |
| SCHEMBL30322813 | 0.74 | PTGS2 (0.39) | CYP2C9CYP2C19CA12CA1CA2 | |
| SCHEMBL29224211 | 0.74 | PTGS2 (0.39) | CYP2C9CYP2C19CYP1A2CYP3A4GABRA1 | |
| SCHEMBL8156087 | 0.74 | TP53 (0.58) | GABRB2LMNAGABRA2SMN1; SMN2MEN1 | |
| SCHEMBL29224302 | 0.74 | PTGS2 (0.41) | CYP2C9CYP2C19CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12252511-B2 | Process for the preparation of cyclic depsipeptides | ONKURE, INC. (US) | 2025-03-18 | — | — | US | claimed |
| US-20250074882-A1 | IMPROVED PROCESS FOR THE PREPARATION OF 5-[(4-BROMO-2-FLUOROPHENYL)AMINO]-4-FLUORO-N-(2HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDE | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2025-03-06 | — | — | US | claimed |
| CN-117843715-A | Liquid phase synthesis method of melanoputan-II | 浙江工业大学 | 2024-04-09 | — | — | CN | claimed |
| CN-117843761-A | Method for preparing melanocortin analogue cyclic peptide drug based on hydrophobic label carrier | 浙江工业大学 | 2024-04-09 | — | — | CN | claimed |
| CN-117736262-A | Preparation method of tripeptide-1 | 深圳创元生物医药科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| EP-4201951-B1 | METHOD FOR PEPTIDE SYNTHESIS | BACHEM HOLDING AG (CH) | 2023-11-22 | — | — | EP | claimed |
| WO-2023117904-A1 | METHOD FOR PEPTIDE SYNTHESIS | BACHEM HOLDING AG (CH) | 2023-06-29 | — | — | WO | claimed |
| EP-4201951-A1 | METHOD FOR PEPTIDE SYNTHESIS | Bachem Holding AG (CH) | 2023-06-28 | — | — | EP | claimed |
| CN-115093460-A | Method for synthesizing linaclotide intermediate and linaclotide in full liquid phase | 浙江工业大学 | 2022-09-23 | — | — | CN | claimed |
| US-9353147-B2 | Method for producing peptide | AJINOMOTO CO., INC. (JP) | 2016-05-31 | — | — | US | claimed |
| US-20140088291-A1 | METHOD FOR PRODUCING PEPTIDE | AJINOMOTO CO., INC. (JP) | 2014-03-27 | — | — | US | claimed |
| US-12637431-B2 | Process for the preparation of 5-[[[(2S)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl] [(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino] methyl-2-methoxybenzoic acid and its polymorphs thereof | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2026-05-26 | — | — | US | disclosed |
| US-20260137765-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF | INSTITUT CURIE (FR) | 2026-05-21 | — | — | US | disclosed |
| CN-121889409-A | Method for producing peptide compounds using independent condensing agents | 中外制药株式会社 | 2026-04-17 | — | — | CN | disclosed |
| EP-3916000-B1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTING GROUP-FORMING REAGENT, AND AROMATIC HETEROCYCLIC COMPOUND | FUJIFILM CORP (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-8546534-B2 | Branched chain-containing aromatic compound | AJINOMOTO CO., INC. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2612845-A1 | AROMATIC COMPOUND CONTAINING SPECIFIC BRANCH | Ajinomoto Co., Inc. (JP) | 2013-07-10 | — | — | EP | disclosed |
| EP-2518041-A1 | BENZYL COMPOUND | Ajinomoto Co., Inc. (JP) | 2012-10-31 | — | — | EP | disclosed |
| US-20120059149-A1 | BRANCHED CHAIN-CONTAINING AROMATIC COMPOUND | AJINOMOTO CO. INC. (JP) | 2012-03-08 | — | — | US | disclosed |
| US-20110160433-A1 | BENZYLIC COMPOUND | AJINOMOTO CO., INC. (JP) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160433-A1 | BENZYLIC COMPOUND | VIP, NGLY1, FURIN | CYP2C9 1641/4885CYP2C19 1494/4885CA12 368/4885 |
| US-20120059149-A1 | BRANCHED CHAIN-CONTAINING AROMATIC COMPOUND | VIP, BCAT2, IAPP | CYP2C9 2936/4885CYP2C19 3470/4885CA12 2862/4885 |
| US-20140088291-A1 | METHOD FOR PRODUCING PEPTIDE | ANPEP, NPPA, LNPEP | CYP2C9 4796/4885CYP2C19 4855/4885CA12 414/4885 |
| US-20250074882-A1 | IMPROVED PROCESS FOR THE PREPARATION OF 5-[(4-BROMO-2-FLUOROPHENYL)AMINO]-4-FLUORO-N-(2HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDE | ABL1, JAK1, FGFR1 | CYP2C9 96/4885CYP2C19 101/4885CA12 4410/4885 |
| US-20260137765-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF | STXBP1, HBB, UPF1 | CYP2C9 4711/4885CYP2C19 4877/4885CA12 4676/4885 |
| US-12637431-B2 | Process for the preparation of 5-[[[(2S)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl] [(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino] methyl-2-methoxybenzoic acid and its polymorphs thereof | OPRD1, OPRK1, OPRM1 | CYP2C9 41/4885CYP2C19 99/4885CA12 4051/4885 |
| US-12252511-B2 | Process for the preparation of cyclic depsipeptides | VIP, LPXN, NGLY1 | CYP2C9 1698/4885CYP2C19 1630/4885CA12 2141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.